2025 Volume 42 Issue 3 Pages 178-182
The Drug Information Association (DIA) is a global non–profit organization that supports innovation in the research, development, and life cycle management of pharmaceuticals, medical devices, regenerative medicine products, and other medical products through educational activities and the exchange of information and discussion between regulatory authorities, industry, academia, and patients. It is a global non–profit organization with more than 10,000 members worldwide.
DIA's activities involve stakeholders from industry, government, and academia involved in the development of medical products in a variety of professional communities, drawing on their experience in their areas of expertise to improve the healthcare industry in Japan.
A collaborative session with the Japanese Society for Neurotherapeutics, which conducts industry–government–academia exchanges, clinical trial support, and clinical research education with the goal of establishing superior therapies, was also planned at the meeting, where industry, government, and academia collaborated to discuss drug discovery and patient and citizen involvement. And the collaboration between the Japanese Society for Neurotherapeutics and DIA, which will not be limited to the Japan Annual Conference, is expected to promote the development of treatments for neurological diseases.
